News
Sildenafil citrate during labor did not improve perinatal outcomes potentially related to intrapartum hypoxia despite ...
10h
Zacks Investment Research on MSNBristol Myers Squibb (BMY) Exceeds Market Returns: Some Facts to ConsiderIn the latest trading session, Bristol Myers Squibb (BMY) closed at $49, marking a +1.22% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.09%. The the ...
This was the stock's second consecutive day of gains.
When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...
A groundbreaking lung cancer screening project co-led by the University of Kentucky Markey Cancer Center and the University ...
Giving patients more direct control over their healthcare data is a frequent talking point among healthcare leaders. | The ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...
Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.
Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do ...
Brian Peters started his new role as SVP of the AI Squared division at Apimeds Pharmaceuticals. Pharma market research firm Konovo named Tim Albury as CFO. Tenpoint Therapeutics announced the ...
The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results